Systemic lupus erythematosus and the brain: What mice are telling us

Neurochemistry International

Volumn 50, Issue 1, 2007, Pages 5-11

  Alexander, Jessy J ^a   Quigg, Richard J ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Animal models; Brain; Pathophysiology; Systemic lupus erythematosus

Indexed keywords

BEHAVIOR CHANGE; BLOOD BRAIN BARRIER; BRAIN; CHEMICAL ANALYSIS; COMPLEMENT SYSTEM; DISEASE COURSE; DISEASE MODEL; INBRED STRAIN; METABOLIC ACTIVATION; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NEUROPHYSIOLOGY; NONHUMAN; OBSERVATIONAL STUDY; PRIORITY JOURNAL; SHORT SURVEY; STRUCTURE ANALYSIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; DISEASE MODELS, ANIMAL; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE;

ANIMALIA;

EID: 33845342489     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2006.08.005     Document Type: Short Survey

References (143)

1. Adachi M., Watanabe-Fukunaga R., and Nagata S. Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 1756-1760
2. Akassoglou K., Probert L., Kontogeorgos G., and Kollias G. Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice. J. Immunol. 158 (1997) 438-445
3. Akassoglou K., Bauer J., Kassiotis G., Pasparakis M., Lassmann H., Kollias G., and Probert L. Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy. Am. J. Pathol. 153 (1998) 801-813
4. Alexander J.J., Hack B.K., Cunningham P.N., and Quigg R.J. A protein with characteristics of factor H is present on rodent platelets and functions as the immune adherence receptor. J. Biol. Chem. 276 (2001) 32129-32135
5. Alexander J.J., Bao L., Jacob A., Kraus D.M., Holers V.M., and Quigg R.J. Administration of the soluble complement inhibitor, Crry-Ig, reduces inflammation and aquaporin 4 expression in lupus cerebritis. Biochim. Biophys. Acta 1639 (2003) 169-176
6. Alexander J.J., Jacob A., Bao L., MacDonald R.L., and Quigg R.J. Complement-dependent apoptosis and inflammatory gene changes in murine lupus cerebritis. J. Immunol. 175 (2005) 8312-8319
7. Alexander J.J., Zwingmann C., and Quigg R. MRL/lpr mice have alterations in brain metabolism as shown with [(1)H-(13)C] NMR spectroscopy. Neurochem. Int. (2005)
8. Alexander J.J., Zwingmann C., and Quigg R. MRL/lpr mice have alterations in brain metabolism as shown with [(1)H-(13)C] NMR spectroscopy. Neurochem. Int. (2005)
9. Alexander J.J., Zwingmann C., and Quigg R. MRL/lpr mice have alterations in brain metabolism as shown with [(1)H-(13)C] NMR spectroscopy. Neurochem. Int. (2005)
10. Alexander J.J., Zwingmann C., and Quigg R. MRL/lpr mice have alterations in brain metabolism as shown with [(1)H-(13)C] NMR spectroscopy. Neurochem. Int. (2005)
11. Alexander J.J., Zwingmann C., and Quigg R. MRL/lpr mice have alterations in brain metabolism as shown with [(1)H-(13)C] NMR spectroscopy. Neurochem. Int. (2005)
12. Anderson K.K., Ballok D.A., Prasad N., Szechtman H., and Sakic B. Impaired response to amphetamine and neuronal degeneration in the nucleus accumbens of autoimmune MRL-lpr mice. Behav. Brain Res. 166 (2006) 32-38
13. Andrews B.S., Eisenberg R.A., Theofilopoulos A.N., Izui S., Wilson C.B., McConahey P.J., Murphy E.D., Roths J.B., and Dixon F.J. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J. Exp. Med. 148 (1978) 1198-1215
14. Arabo A., Costa O., Dubois M., Tron F., and Caston J. Effects of systemic lupus erythematosus on spatial cognition and cerebral regional metabolic reactivity in B × SB lupus-prone mice. Neuroscience 135 (2005) 691-702
15. Arabo A., Costa O., Tron F., and Caston J. Spatial and motor abilities during the course of autoimmune disease in (NZW × BXSB)F1 lupus-prone mice. Behav. Brain Res. 165 (2005) 126-137
16. Asherson R.A., Denburg S.D., Denburg J.A., Carbotte R.M., and Futrell N. Current concepts of neuropsychiatric systemic lupus erythematosus (NP-SLE). Postgrad. Med. J 69 (1993) 602-608
17. Ballok D.A., Szechtman H., and Sakic B. Taste responsiveness and diet preference in autoimmune MRL mice. Behav. Brain Res. 140 (2003) 119-130
18. Belmont H.M., Hopkins P., Edelson H.S., Kaplan H.B., Ludewig R., Weissmann G., and Abramson S. Complement activation during systemic lupus erythematosus. C3a and C5a anaphylatoxins circulate during exacerbations of disease. Arthrit. Rheum. 29 (1986) 1085-1089
19. Boswell J.M., Yui M.A., Burt D.W., and Kelley V.E. Increased tumor necrosis factor and IL-1 beta gene expression in the kidneys of mice with lupus nephritis. J. Immunol. 141 (1988) 3050-3054
20. Boumpas D.T., Austin III H.A., Fessler B.J., Balow J.E., Klippel J.H., and Lockshin M.D. Systemic lupus erythematosus: emerging concepts. Part 1. Renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease. Ann. Intern. Med. 122 (1995) 940-950
21. Bracci-Laudiero L., Aloe L., Lundeberg T., Theodorsson E., and Stenfors C. Altered levels of neuropeptides characterize the brain of lupus prone mice. Neurosci. Lett. 275 (1999) 57-60
22. Brey R.L., Amato A.A., Kagan-Hallet K., Rhine C.B., and Stallworth C.L. Anti-intercellular adhesion molecule-1 (ICAM-1) antibody treatment prevents central and peripheral nervous system disease in autoimmune-prone mice. Lupus 6 (1997) 645-651
23. Brey R.L., Sakic B., Szechtman H., and Denburg J.A. Animal models for nervous system disease in systemic lupus erythematosus. Ann. N.Y. Acad. Sci. 823 (1997) 97-106
24. Brooks W.M., Sabet A., Sibbitt Jr. W.L., Barker P.B., van Zijl P.C., Duyn J.H., and Moonen C.T. Neurochemistry of brain lesions determined by spectroscopic imaging in systemic lupus erythematosus. J. Rheumatol. 24 (1997) 2323-2329
25. Brooks W.M., Sabet A., Sibbitt Jr. W.L., Barker P.B., van Zijl P.C., Duyn J.H., and Moonen C.T. Neurochemistry of brain lesions determined by spectroscopic imaging in systemic lupus erythematosus. J. Rheumatol. 24 (1997) 2323-2329
26. Brooks W.M., Stidley C.A., Petropoulos H., Jung R.E., Weers D.C., Friedman S.D., Barlow M.A., Sibbitt Jr. W.L., and Yeo R.A. Metabolic and cognitive response to human traumatic brain injury: a quantitative proton magnetic resonance study. J. Neurotrauma 17 (2000) 629-640
27. Carbotte R.M., Denburg S.D., and Denburg J.A. Prevalence of cognitive impairment in systemic lupus erythematosus. J. Nerv. Ment. Dis. 174 (1986) 357-364
28. Carbotte R.M., Denburg S.D., and Denburg J.A. Cognitive deficit associated with rheumatic diseases: neuropsychological perspectives. Arthrit. Rheum. 38 (1995) 1363-1374
29. Carbotte R.M., Denburg S.D., and Denburg J.A. Cognitive dysfunction in systemic lupus erythematosus is independent of active disease. J. Rheumatol. 22 (1995) 863-867
30. Cooper G.S., Dooley M.A., Treadwell E.L., St Clair E.W., Parks G.G., and Gilkeson G.S. Hormonal, environmental, and infectious risk factors for developing systemic lupus erythematosus. Arthrit. Rheum. 41 (1998) 1714-1724
31. Davson H., and Segal M.B. Physiology of the CSF and the Blood-Brain Barrier (1995), CRC, New York
32. Davson H., Zlokovic B.V., Rakic L., and Segal M.B. An Introduction to the Blood-Brain Barrier (1993), Macmillan, London
33. De S.N., Bartolozzi M.L., Guidi L., Stromillo M.L., and Federico A. Magnetic resonance spectroscopy as a measure of brain damage in multiple sclerosis. J. Neurol. Sci. 233 (2005) 203-208
34. Denburg J.A., Carbotte R.M., and Denburg S.D. Neuronal antibodies and cognitive function in systemic lupus erythematosus. Neurology 37 (1987) 464-467
35. Denburg S.D., Carbotte R.M., and Denburg J.A. Cognitive impairment in systemic lupus erythematosus: a neuropsychological study of individual and group deficits. J. Clin. Exp. Neuropsychol. 9 (1987) 323-339
36. deVries B., Kohl J., Leclercq W.K., Wolfs T.G., van Bijnen A.A., Heeringa P., and Buurman W.A. Complement factor C5a mediates renal ischemia-reperfusion injury independent from neutrophils. J. Immunol. 170 (2003) 3883-3889
37. Dienel G.A., and Cruz N.F. Neighborly interactions of metabolically-activated astrocytes in vivo. Neurochem. Int. 43 (2003) 339-354
38. Eichenbaum H., Dusek J., Young B., and Bunsey M. Neural mechanisms of declarative memory. Cold Spring Harb. Symp. Quant. Biol. 61 (1996) 197-206
39. Farkas I., Baranyi L., Liposits Z.S., Yamamoto T., and Okada H. Complement C5a anaphylatoxin fragment causes apoptosis in TGW neuroblastoma cells. Neuroscience 86 (1998) 903-911
40. Farkas I., Baranyi L., Takahashi M., Fukuda A., Liposits Z., Yamamoto T., and Okada H. A neuronal C5a receptor and an associated apoptotic signal transduction pathway. J. Physiol. 507 Pt 3 (1998) 679-687
41. Farries T.C., and Atkinson J.P. Evolution of the complement system. Immunol. Today 12 (1991) 295-300
42. Ferbinteanu J., and Shapiro M.L. Prospective and retrospective memory coding in the hippocampus. Neuron 40 (2003) 1227-1239
43. Ferbinteanu J., Ray C., and McDonald R.J. Both dorsal and ventral hippocampus contribute to spatial learning in Long-Evans rats. Neurosci. Lett. 345 (2003) 131-135
44. Fessler B.J., and Boumpas D.T. Severe major organ involvement in systemic lupus erythematosus, diagnosis and management. Rheum. Dis. Clin. North Am. 21 (1995) 81-98
45. Fisk J.D., Eastwood B., Sherwood G., and Hanly J.G. Patterns of cognitive impairment in patients with systemic lupus erythematosus. Br. J. Rheumatol. 32 (1993) 458-462
46. Forster M.J., Retz K.C., Popper M.D., and Lal H. Age-dependent enhancement of diazepam sensitivity is accelerated in New Zealand Black mice. Life Sci. 38 (1986) 1433-1439
47. Forster M.J., Popper M.D., Retz K.C., and Lal H. Age differences in acquisition and retention of one-way avoidance learning in C57BL/6NNia and autoimmune mice. Behav. Neural Biol. 49 (1988) 139-151
48. Freeman J.J., and Jenden D.J. The source of choline for acetylcholine synthesis in brain. Life Sci. 19 (1976) 949-961
49. Futrell N., Schultz L.R., and Millikan C. Central nervous system disease in patients with systemic lupus erythematosus. Neurology 42 (1992) 1649-1657
50. Ginsburg K.S., Wright E.A., Larson M.G., Fossel A.H., Albert M., Schur P.H., and Liang M.H. A controlled study of the prevalence of cognitive dysfunction in randomly selected patients with systemic lupus erythematosus. Arthrit. Rheum. 35 (1992) 776-782
51. Gladden L.B. Lactate metabolism: a new paradigm for the third millennium. J. Physiol. 558 (2004) 5-30
52. Hanly J.G., Fisk J.D., Sherwood G., and Eastwood B. Clinical course of cognitive dysfunction in systemic lupus erythematosus. J. Rheumatol. 21 (1994) 1825-1831
53. Harris E.N., and Pierangeli S. Antiphospholipid antibodies and cerebral lupus. Ann. N.Y. Acad. Sci. 823 (1997) 270-278
54. Head J.R., and Griffin W.S. Functional capacity of solid tissue transplants in the bra evidence for immunological privilege. Proc. R. Lond. Soc. B. Biol. Sci. 224 (1985) 375-387
55. Heavner J.E., Colaianne J., and Roper M. Lactate dehydrogenase isoenzymes in blood and cerebrospinal fluid from healthy beagles. Am. J. Vet. Res. 47 (1986) 1772-1775
56. Hengartner M.O. The biochemistry of apoptosis. Nature 407 (2000) 770-776
57. Hertz L. The astrocyte-neuron lactate shuttle: a challenge of a challenge. J. Cereb. Blood Flow Metab. 24 (2004) 1241-1248
58. Hertz L., and Dienel G.A. Lactate transport and transporters: general principles and functional roles in brain cells. J. Neurosci. Res. 79 (2005) 11-18
59. Hess D.C., Taormina M., Thompson J., Sethi K.D., Diamond B., Rao R., Chamberlain C.R., and Feldman D.S. Cognitive and neurologic deficits in the MRL/lpr mouse: a clinicopathologic study. J. Rheumatol. 20 (1993) 610-617
60. Hopkins P., Belmont H.M., Buyon J., Philips M., Weissmann G., and Abramson S.B. Increased levels of plasma anaphylatoxins in systemic lupus erythematosus predict flares of the disease and may elicit vascular injury in lupus cerebritis. Arthrit. Rheum. 31 (1988) 632-641
61. Iyer S.S., Barton J.A., Bourgoin S., and Kusner D.J. Phospholipases D1 and D2 coordinately regulate macrophage phagocytosis. J. Immunol. 173 (2004) 2615-2623
62. Izui S., Iwamoto M., Fossati L., Merino R., Takahashi S., and Ibnou-Zekri N. The Yaa gene model of systemic lupus erythematosus. Immunol. Rev. 144 (1995) 137-156
63. Jenden D.J. Difficulties in using animal data to predict pharmacological response in man. Neurosci. Biobehav. Rev. 15 (1991) 105-107
64. Jennekens F.G., and Kater L. The central nervous system in systemic lupus erythematosus. Part 2. Pathogenetic mechanisms of clinical syndromes: a literature investigation. Rheumatology (Oxford) 41 (2002) 619-630
65. Jongen P.J., Doesburg W.H., Ibrahim-Stappers J.L., Lemmens W.A., Hommes O.R., and Lamers K.J. Cerebrospinal fluid C3 and C4 indexes in immunological disorders of the central nervous system. Acta Neurol. Scand. 101 (2000) 116-121
66. Jongeneel C.V., cha-Orbea H., and Blankenstein T. A polymorphic microsatellite in the tumor necrosis factor alpha promoter identifies an allele unique to the NZW mouse strain. J. Exp. Med. 171 (1990) 2141-2146
67. Kaell A.T., Shetty M., Lee B.C., and Lockshin M.D. The diversity of neurologic events in systemic lupus erythematosus. Prospective clinical and computed tomographic classification of 82 events in 71 patients. Arch. Neurol. 43 (1986) 273-276
68. Kaiser W., and Bygrave F.L. Incorporation of choline into the outer and inner membranes of isolated rat liver mitochondria. Eur. J. Biochem. 4 (1968) 582-585
69. Keenan P.A., and Conway J. Psychiatric and neurocognitive concomitants of systemic lupus erythematosus. Ann. N.Y. Acad. Sci. 823 (1997) 69-80
70. Kier A.B. Clinical neurology and brain histopathology in NZB/NZW F1 lupus mice. J. Comp. Pathol. 102 (1990) 165-177
71. Kimelberg H.K. The role of hypotheses in current research, illustrated by hypotheses on the possible role of astrocytes in energy metabolism and cerebral blood flow: from Newton to now. J. Cereb. Blood Flow Metab. 24 (2004) 1235-1239
72. Koffler S. The role of neuropsychological testing in systemic lupus erythematosus. In: Lahita R. (Ed). Systemic Lupus Erythematosus (1987), John Wiley and Sons
73. Komatsu N., Kodama K., Yamanouchi N., Okada S., Noda S., Nawata Y., Takabayashi K., Iwamoto I., Saito Y., Uchida Y., Ito H., Yoshikawa K., and Sato T. Decreased regional cerebral metabolic rate for glucose in systemic lupus erythematosus patients with psychiatric symptoms. Eur. Neurol. 42 (1999) 41-48
74. Kotzin B.L. Systemic lupus erythematosus. Cell 85 (1996) 303-306
75. Kowal C., DeGiorgio L.A., Nakaoka T., Hetherington H., Huerta P.T., Diamond B., and Volpe B.T. Cognition and immunity; antibody impairs memory. Immunity 21 (2004) 179-188
76. Lauwerys B.R., and Houssiau F.A. Cytokines: clues to the pathogenesis of SLE. Lupus 7 (1998) 211-213
77. Lauwerys B.R., and Houssiau F.A. Involvement of cytokines in the pathogenesis of systemic lupus erythematosus. Adv. Exp. Med. Biol. 520 (2003) 237-251
78. Lawrence R.C., Helmick C.G., Arnett F.C., Deyo R.A., Felson D.T., Giannini E.H., Heyse S.P., Hirsch R., Hochberg M.C., Hunder G.G., Liang M.H., Pillemer S.R., Steen V.D., and Wolfe F. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthrit. Rheum. 41 (1998) 778-799
79. Leutgeb S., Ragozzino K.E., and Mizumori S.J. Convergence of head direction and place information in the CA1 region of hippocampus. Neuroscience 100 (2000) 11-19
80. Lindal E., Thorlacius S., Steinsson K., and Stefansson J.G. Psychiatric disorders among subjects with systemic lupus erythematosus in an unselected population. Scand. J. Rheumatol. 24 (1995) 346-351
81. Liu J., and Beller D. Aberrant production of IL-12 by macrophages from several autoimmune-prone mouse strains is characterized by intrinsic and unique patterns of NF-kappa B expression and binding to the IL-12 p40 promoter. J. Immunol. 169 (2002) 581-586
82. Maldonado M.A., Kakkanaiah V., MacDonald G.C., Chen F., Reap E.A., Balish E., Farkas W.R., Jennette J.C., Madaio M.P., Kotzin B.L., Cohen P.L., and Eisenberg R.A. The role of environmental antigens in the spontaneous development of autoimmunity in MRL-lpr mice. J. Immunol. 162 (1999) 6322-6330
83. Marshall D., Dangerfield J.P., Bhatia V.K., Larbi K.Y., Nourshargh S., and Haskard D.O. MRL/lpr lupus-prone mice show exaggerated ICAM-1-dependent leucocyte adhesion and transendothelial migration in response to TNF-alpha. Rheumatology (Oxford) 42 (2003) 929-934
84. McCune W.J., and Golbus J. Neuropsychiatric lupus. Rheum. Dis. Clin. North Am. 14 (1988) 149-167
85. Mills J.A. Systemic lupus erythematosus. N. Engl. J Med. 330 (1994) 1871-1879
86. Moore P.M. Evidence for bound antineuronal antibodies in brains of NZB/W mice. J. Neuroimmunol. 38 (1992) 147-154
87. Moritani T., Hiwatashi A., Shrier D.A., Wang H.Z., Numaguchi Y., and Westesson P.L. CNS vasculitis and vasculopathy: efficacy and usefulness of diffusion-weighted echoplanar MR imaging. Clin. Imag. 28 (2004) 261-270
88. Nauta A.J., Daha M.R., Tijsma O., van de W.B., Tedesco F., and Roos A. The membrane attack complex of complement induces caspase activation and apoptosis. Eur. J. Immunol. 32 (2002) 783-792
89. Otte A., Weiner S.M., Peter H.H., Mueller-Brand J., Goetze M., Moser E., Gutfleisch J., Hoegerle S., Juengling F.D., and Nitzsche E.U. Brain glucose utilization in systemic lupus erythematosus with neuropsychiatric symptoms: a controlled positron emission tomography study. Eur. J. Nucl. Med. 24 (1997) 787-791
90. Parnetti L., Reboldi G.P., and Gallai V. Cerebrospinal fluid pyruvate levels in Alzheimer's disease and vascular dementia. Neurology 54 (2000) 735-737
91. Pellerin L. Lactate as a pivotal element in neuron-glia metabolic cooperation. Neurochem. Int. 43 (2003) 331-338
92. Pellerin L., Pellegri G., Bittar P.G., Charnay Y., Bouras C., Martin J.L., Stella N., and Magistretti P.J. Evidence supporting the existence of an activity-dependent astrocyte-neuron lactate shuttle. Dev. Neurosci. 20 (1998) 291-299
93. Petris M. Systemic lupus erythematosus. In: Rich R.R. (Ed). Clinical Immunology: Principles and Practice (1996) 1072-1092
94. Poucet B., and Benhamou S. The neuropsychology of spatial cognition in the rat. Crit. Rev. Neurobiol. 11 (1997) 101-120
95. Poucet B., Lenck-Santini P.P., Paz-Villagran V., and Save E. Place cells, neocortex and spatial navigation: a short review. J. Physiol. Paris 97 (2003) 537-546
96. Poucet B., Lenck-Santini P.P., Hok V., Save E., Banquet J.P., Gaussier P., and Muller R.U. Spatial navigation and hippocampal place cell firing: the problem of goal encoding. Rev. Neurosci. 15 (2004) 89-107
97. Ramonet D., Rodriguez M.J., Fredriksson K., Bernal F., and Mahy N. In vivo neuroprotective adaptation of the glutamate/glutamine cycle to neuronal death. Hippocampus 14 (2004) 586-594
98. Raptopoulou A., Sidiropoulos P., and Boumpas D. Ovarian failure and strategies for fertility preservation in patients with systemic lupus erythematosus. Lupus 13 (2004) 887-890
99. Rood M.J., Keijsers V., van der Linden M.W., Tong T.Q., Borggreve S.E., Verweij C.L., Breedveld F.C., and Huizinga T.W. Neuropsychiatric systemic lupus erythematosus is associated with imbalance in interleukin 10 promoter haplotypes. Ann. Rheum. Dis. 58 (1999) 85-89
100. Rudick R.A., and Eskin T.A. Neuropathological features of a lupus-like disorder in autoimmune mice. Ann. Neurol. 14 (1983) 325-332
101. Sabet A., Sibbitt Jr. W.L., Stidley C.A., Danska J., and Brooks W.M. Neurometabolite markers of cerebral injury in the antiphospholipid antibody syndrome of systemic lupus erythematosus. Stroke 29 (1998) 2254-2260
102. Sakic B., Denburg J.A., Denburg S.D., and Szechtman H. Blunted sensitivity to sucrose in autoimmune MRL-lpr mice: a curve-shift study. Brain Res. Bull. 41 (1996) 305-311
103. Sakic B., Szechtman H., Braciak T., Richards C., Gauldie J., and Denburg J.A. Reduced preference for sucrose in autoimmune mice: a possible role of interleukin-6. Brain Res. Bull. 44 (1997) 155-165
104. Sakic B., Szechtman H., Denburg J.A., Gorny G., Kolb B., and Whishaw I.Q. Progressive atrophy of pyramidal neuron dendrites in autoimmune MRL-lpr mice. J. Neuroimmunol. 87 (1998) 162-170
105. Sakic B., Maric I., Koeberle P.D., Millward J.M., Szechtman H., Maric D., and Denburg J.A. Increased TUNEL staining in brains of autoimmune Fas-deficient mice. J. Neuroimmunol. 104 (2000) 147-154
106. Sakic B., Kirkham D.L., Ballok D.A., Mwanjewe J., Fearon I.M., Macri J., Yu G., Sidor M.M., Denburg J.A., Szechtman H., Lau J., Ball A.K., and Doering L.C. Proliferating brain cells are a target of neurotoxic CSF in systemic autoimmune disease. J. Neuroimmunol. 169 (2005) 68-85
107. Sayah S., Ischenko A.M., Zhakhov A., Bonnard A.S., and Fontaine M. Expression of cytokines by human astrocytomas following stimulation by C3a and C5a anaphylatoxins: specific increase in interleukin-6 mRNA expression. J. Neurochem. 72 (1999) 2426-2436
108. Schnider A., Bassetti C., Schnider A., Gutbrod K., and Ozdoba C. Very severe amnesia with acute onset after isolated hippocampal damage due to systemic lupus erythematosus. J. Neurol. Neurosurg. Psychiatry 59 (1995) 644-646
109. Segal M.B., and Zloković B.V. The Blood-Brain Barrier, Amino Acids and Peptides (1990), Kluwer, Dordrecht, Boston, London
110. Sibbitt Jr. W.L., Haseler L.J., Griffey R.H., Hart B.L., Sibbitt R.R., and Matwiyoff N.A. Analysis of cerebral structural changes in systemic lupus erythematosus by proton MR spectroscopy. AJNR Am. J. Neuroradiol. 15 (1994) 923-928
111. Sibbitt Jr. W.L., Jung R.E., and Brooks W.M. Neuropsychiatric systemic lupus erythematosus. Compr. Ther. 25 (1999) 198-208
112. Sibley J.T., Olszynski W.P., Decoteau W.E., and Sundaram M.B. The incidence and prognosis of central nervous system disease in systemic lupus erythematosus. J. Rheumatol. 19 (1992) 47-52
113. Sidor M.M., Sakic B., Malinowski P.M., Ballok D.A., Oleschuk C.J., and Macri J. Elevated immunoglobulin levels in the cerebrospinal fluid from lupus-prone mice. J. Neuroimmunol. (2005)
114. Smith D., Pernet A., Hallett W.A., Bingham E., Marsden P.K., and Amiel S.A. Lactate: a preferred fuel for human brain metabolism in vivo. J. Cereb. Blood Flow Metab. 23 (2003) 658-664
115. Soane L., Cho H.J., Niculescu F., Rus H., and Shin M.L. C5b-9 terminal complement complex protects oligodendrocytes from death by regulating Bad through phosphatidylinositol 3-kinase/Akt pathway. J. Immunol. 167 (2001) 2305-2311
116. Spencer Jr. D.G., Humphries K., Mathis D., and Lal H. Behavioral impairments related to cognitive dysfunction in the autoimmune New Zealand black mouse. Behav. Neurosci. 100 (1986) 353-358
117. Steinberg A.D. Systemic lupus erythematosus: theories of pathogenesis and approach to therapy. Clin. Immunol. Immunopathol. 72 (1994) 171-176
118. Szelenyi J. Cytokines and the central nervous system. Brain Res. Bull. 54 (2001) 329-338
119. Tatsukawa H., Ishii K., Haranaka M., Kumagi M., Hino I., and Yoshimatsu H. Evaluation of average amount of cerebral blood flow measured by brain perfusion index in patients with neuropsychiatric systemic lupus erythematosus. Lupus 14 (2005) 445-449
120. Theofilopoulos A.N., and Dixon F.J. Murine models of systemic lupus erythematosus. Adv. Immunol. 37 (1985) 269-390
121. Theofilopoulos A.N., Kofler R., Singer P.A., and Dixon F.J. Molecular genetics of murine lupus models. Adv. Immunol. 46 (1989) 61-109
122. Tin S.K., Xu Q., Thumboo J., Lee L.Y., Tse C., and Fong K.Y. Novel brain reactive autoantibodies: prevalence in systemic lupus erythematosus and association with psychoses and seizures. J. Neuroimmunol. 169 (2005) 153-160
123. Tomita M., Khan R.L., Blehm B.H., and Santoro T.J. The potential pathogenetic link between peripheral immune activation and the central innate immune response in neuropsychiatric systemic lupus erythematosus. Med. Hypoth. 62 (2004) 325-335
124. Utset T.O., Golden M., Siberry G., Kiri N., Crum R.M., and Petri M. Depressive symptoms in patients with systemic lupus erythematosus: association with central nervous system lupus and Sjogren's syndrome. J. Rheumatol. 21 (1994) 2039-2045
125. Uwai M., Terui Y., Mishima Y., Tomizuka H., Ikeda M., Itoh T., Mori M., Ueda M., Inoue R., Yamada M., Hayasawa H., Horiuchi T., Niho Y., Matsumoto M., Ishizaka Y., Ikeda K., Ozawa K., and Hatake K. A new apoptotic pathway for the complement factor B-derived fragment Bb. J. Cell Physiol. 185 (2000) 280-292
126. Vogelweid C.M., Johnson G.C., Besch-Williford C.L., Basler J., and Walker S.E. Inflammatory central nervous system disease in lupus-prone MRL/lpr mice: comparative histologic and immunohistochemical findings. J. Neuroimmunol. 35 (1991) 89-99
127. Vogelweid C.M., Wright D.C., Johnson J.C., Hewett J.E., and Walker S.E. Evaluation of memory, learning ability, and clinical neurologic function in pathogen-free mice with systemic lupus erythematosus. Arthrit. Rheum. 37 (1994) 889-897
128. Walsh S.J., Algert C., Gregorio D.I., Reisine S.T., and Rothfield N.F. Divergent racial trends in mortality from systemic lupus erythematosus. J. Rheumatol. 22 (1995) 1663-1668
129. Watanabe-Fukunaga R., Brannan C.I., Copeland N.G., Jenkins N.A., and Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356 (1992) 314-317
130. Watkins L.R., Maier S.F., and Goehler L.E. Cytokine-to-brain communication: a review and analysis of alternative mechanisms. Life Sci. 57 (1995) 1011-1026
131. Weiner S.M., Otte A., Schumacher M., Brink I., Juengling F.D., Sobanksi T., Nitzsche E.U., and Peter H.H. Alterations of cerebral glucose metabolism indicate progress to severe morphological brain lesions in neuropsychiatric systemic lupus erythematosus. Lupus 9 (2000) 386-389
132. Weiner S.M., Otte A., Schumacher M., Klein R., Gutfleisch J., Brink I., Otto P., Nitzsche E.U., Moser E., and Peter H.H. Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET. Ann. Rheum. Dis. 59 (2000) 377-385
133. West S.G. Neuropsychiatric lupus. Rheum. Dis. Clin. North Am. 20 (1994) 129-158
134. West S.G. Lupus and the central nervous system. Curr. Opin. Rheumatol. 8 (1996) 408-414
135. West S.G., Emlen W., Wener M.H., and Kotzin B.L. Neuropsychiatric lupus erythematosus: a 10-year prospective study on the value of diagnostic tests. Am. J. Med. 99 (1995) 153-163
136. Wong K.L., Woo E.K., Yu Y.L., and Wong R.W. Neurological manifestations of systemic lupus erythematosus: a prospective study. Q. J. Med. 81 (1991) 857-870
137. Wright J.W., Alt J.A., Turner G.D., and Krueger J.M. Differences in spatial learning comparing transgenic p75 knockout, New Zealand Black, C57BL/6, and Swiss Webster mice. Behav. Brain Res. 153 (2004) 453-458
138. Wright J.W., Murphy E.S., Elijah I.E., Holtfreter K.L., Davis C.J., Olson M.L., Muhunthan K., and Harding J.W. Influence of hippocampectomy on habituation, exploratory behavior, and spatial memory in rats. Brain Res. 1023 (2004) 1-14
139. Yesavage J.A., Holman C.A., and Berger P.A. Cerebrospinal fluid lactate levels and aging: findings in normals and patients with major depressive disorders. Gerontology 28 (1982) 377-380
140. Zameer A., and Hoffman S.A. Immunoglobulin binding to brain in autoimmune mice. J. Neuroimmunol. 120 (2001) 10-18
141. Zameer A., and Hoffman S.A. Increased ICAM-1 and VCAM-1 expression in the brains of autoimmune mice. J. Neuroimmunol. 142 (2003) 67-74
142. Zeisel S.H. Dietary choline: biochemistry, physiology, and pharmacology. Annu. Rev. Nutr. 1 (1981) 95-121
143. Zhou G., Fujio K., Sadakata A., Okamoto A., Yu R., and Yamamoto K. Identification of systemically expanded activated T cell clones in MRL/lpr and NZB/W F1 lupus model mice. Clin. Exp. Immunol. 136 (2004) 448-455